8 January, 2015 by The TZ Newswire Staff Comments Off on GW Pharmaceuticals Exposes Risks of Investing in Medical Marijuana
GW Pharmaceuticals Exposes Risks of Investing in Medical Marijuana
The phase 3 failure of Sativex for cancer pain reminds investors of the risks of investing in marijuana stocks.
8 January, 2015 by The TZ Newswire Staff Comments Off on Job cuts in 2014 were at lowest level since 1997
Job cuts in 2014 were at lowest level since 1997
Job cuts announced last year by American employers reached levels not seen since before the recession, new data finds, and they fell for the second consecutive month in December.
read more
8 January, 2015 by The TZ Newswire Staff Comments Off on 84% Of America Is Freezing This Morning, "No Relief In Sight"
84% Of America Is Freezing This Morning, "No Relief In Sight"
Schools in Chicago, Boston and other large cities closed on Thursday as sub-zero temperatures and bitter winds gripped central and eastern United States for a third day and, as Reuters reports, meteorologists warned there was little relief in sight. A stunning 83.8% of America was freezing this morning (and 12.9% below zero) as an Arctic air blast from Canada hit the U.S.
8 January, 2015 by The TZ Newswire Staff Comments Off on Buyside Demands Corporate-Bond Upgrade
Buyside Demands Corporate-Bond Upgrade
Exceptional volatility is driving better price discovery for U.S. corporate bonds, but old market structure issues and trading behaviors persist.
8 January, 2015 by The TZ Newswire Staff Comments Off on Apple and Google’s Next Showdown Coming to a Home Near You
Apple and Google’s Next Showdown Coming to a Home Near You
Houses are getting smarter, and Apple and Google are vying to play a big role in the future of smart home technology.
8 January, 2015 by The TZ Newswire Staff Comments Off on The Biggest Threat to Your Retirement: Your Kids?
The Biggest Threat to Your Retirement: Your Kids?
Everyone knows children are expensive, but if you’re not careful your generosity as a parent could also cost you a secure retirement.
8 January, 2015 by The TZ Newswire Staff Comments Off on Why Seattle Genetics, Inc. Stock Dove 12% in December
Why Seattle Genetics, Inc. Stock Dove 12% in December
Seattle Genetics’ shares get hammered following impressive clinical data from its rivals at the American Society of Hematology’s annual meeting. Find out whether this dip represents a buying opportunity or a red flag.